THNR ETF

$24.12
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 22 holdings— Unlock all holdings(as of Apr 30, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1NVO:OSNovo-Nordisk A/S-Spons Adr14.52%13,608$610.6K••••••••••••••••••••••
2LLYEli Lilly & Co12.44%529$523.1K••••••••••••••••••••••
3REGNRegeneron Pharmaceuticals, Inc.6.16%369$259.1K••••••••••••••••••••••
4AMGNAmgen Inc.5.87%749$246.9K••••••••••••••••••••••
5ARWRArrowhead Pharmaceuticals Inc5.86%3,287$246.3K••••••••••••••••••••••
64519:TKChugai Pharmaceutical Co., Ltd5.72%4,600$240.5K••••••••••••••••••••••
71801:HKInnovent Biologics Inc5.59%20,000$234.8K••••••••••••••••••••••
8ROG:SMRoche Holding Ag4.94%510$207.8K••••••••••••••••••••••
9PFEPfizer, Inc.4.79%7,606$201.2K••••••••••••••••••••••
10MRKMerck & Company Inc4.75%1,763$199.5K••••••••••••••••••••••
111093:HKCSPC Pharmaceutical Group Limited Shs4.59%180,000$192.9K••••••••••••••••••••••
12AZN:LNDeveloped Markets Astrazeneca Plc Sponsored Adr4.58%1,063$192.7K••••••••••••••••••••••
13ABBVAbbvie Inc4.45%907$186.9K••••••••••••••••••••••
144507:JPShionogi & Co Ltd4.39%9,300$184.5K••••••••••••••••••••••
15SRRKScholar Rock Holding Corp2.25%2,005$94.5K••••••••••••••••••••••
16VKTXViking Therapeutics Inc Com2.10%2,818$88.2K••••••••••••••••••••••
17ZEAL:COZealand Pharma As1.83%1,604$76.8K••••••••••••••••••••••
18GPCR:SHStructure Therapeutics Inc Adr1.70%1,738$71.4K••••••••••••••••••••••
19600276:SHJiangsu Hengrui Pharmaceutic1.25%6,200$52.5K••••••••••••••••••••••
20128940:KRHanmi Pharm Co Ltd1.14%158$48.0K••••••••••••••••••••••
2+ more holdings available
See all 22 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

THNR ETF All Holdings

THNR holdings total 22 positions. The top 10 holdings account for 70.6% of the fund, led by Novo-Nordisk A/S-Spons Adr at 14.5%, Eli Lilly & Co at 12.4%, Regeneron Pharmaceuticals, Inc. at 6.2%.

THNR portfolio concentration is relatively high, with the top 10 representing 70.6% of total assets. The largest sector exposure is Health Care at 79.6%.

THNR sector allocation provides a detailed breakdown. THNR overlap tool shows how holdings compare to other funds in your portfolio.

THNR ETF Holdings

22 of 22 holdings

  • 1

    Novo-Nordisk A/S-Spons Adr

    NVO:OSHealth Care
    14.52%
  • 2

    Eli Lilly & Co

    LLYHealth Care
    12.44%
  • 3

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    6.16%
  • 4

    Amgen Inc.

    AMGNHealth Care
    5.87%
  • 5

    Arrowhead Pharmaceuticals Inc

    ARWRHealth Care
    5.86%
  • 6

    Chugai Pharmaceutical Co., Ltd

    4519:TKUnknown
    5.72%
  • 7

    Innovent Biologics Inc

    1801:HKHealth Care
    5.59%
  • 8

    Roche Holding Ag

    ROG:SMUnknown
    4.94%
  • 9

    Pfizer, Inc.

    PFEHealth Care
    4.79%
  • 10

    Merck & Company Inc

    MRKHealth Care
    4.75%
  • 11

    CSPC Pharmaceutical Group Limited Shs

    1093:HKHealth Care
    4.59%
  • 12

    Developed Markets Astrazeneca Plc Sponsored Adr

    AZN:LNHealth Care
    4.58%
  • 13

    Abbvie Inc

    ABBVHealth Care
    4.45%
  • 14

    Shionogi & Co Ltd

    4507:JPUnknown
    4.39%
  • 15

    Scholar Rock Holding Corp

    SRRKHealth Care
    2.25%
  • 16

    Viking Therapeutics Inc Com

    VKTXHealth Care
    2.10%
  • 17

    Zealand Pharma As

    ZEAL:COUnknown
    1.83%
  • 18

    Structure Therapeutics Inc Adr

    GPCR:SHHealth Care
    1.70%
  • 19

    Jiangsu Hengrui Pharmaceutic

    600276:SHUnknown
    1.25%
  • 20

    Hanmi Pharm Co Ltd

    128940:KRUnknown
    1.14%
  • 21

    Invesco Government & Agency Portfolio, Institutional Class

    AGPXXFinancials
    0.89%
  • 22

    Cash & Other

    Other
    0.20%